Akari Therapeutics, Plc (NASDAQ: AKTX) today announced recent developments and supporting data which underscore the differentiation of Coversin.“We are encouraged ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE